Leveljump Healthcare reports FY results
Seeking Alpha ·
Leveljump Healthcare press release ( JUMP:CA ): FY Revenue of $19.1M. Canadian Teleradiology Services, Inc., the Company's 100% owned subsidiary had EBITDA for 2025 of $3.84 million. 2025 Financial Results for fourth quarter and year Revenues of $5.1 million in Q4 2025 and $19.1 million for the year 2025 with a net loss from operations of $ for Q4 2025 and a net loss from operations of $815,018 for the year 2025. EBITDA of $(105,000) for Q4 2025 and $1,662,510 for the year 2025. Financial information for Leveljump Healthcare
AI 시장 분석
Leveljump Healthcare reported annual revenue of $19.1 million for 2025, but posted an operating loss of $815,018. Q4 revenue reached $5.1 million, with its subsidiary Canadian Teleradiology Services achieving $3.84 million in EBITDA. These results highlight challenges in overall profitability, requiring a cautious approach from investors.
상승 영향
- Bio — The subsidiary Canadian Teleradiology Services demonstrated strong growth potential in telemedicine by recording a solid EBITDA of $3.84 million.
하락 영향
- Bio — The annual operating loss of $815k and the transition to a negative EBITDA in Q4 indicate that the pace of profitability improvement is falling short of market expectations.
DYAX 전담 분석
Despite steady top-line growth, the company continues to struggle with operational inefficiencies. The profitability gap remains a key concern, necessitating careful monitoring of cost management strategies going forward.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 48% · Bearish (Short) 52%
357 participants
Related News
- Tenaris upgraded at Morgan Stanley on improving OCTG industry fundamentals
- Flight tracking shows O'Reilly/Genuine Parts transaction more likely - analyst
- Why Micron Stock Just Dropped Again
- Amazon names Dave Treadwell to lead AWS unit after Dave Brown's exit
- US economic activity broadens to almost all Federal Reserve districts: Beige Book
- ExxonMobil Is Poised for a Major Transformation by 2040